AU2001270014A1 - Compositions for identification and isolation of stem cells - Google Patents

Compositions for identification and isolation of stem cells

Info

Publication number
AU2001270014A1
AU2001270014A1 AU2001270014A AU7001401A AU2001270014A1 AU 2001270014 A1 AU2001270014 A1 AU 2001270014A1 AU 2001270014 A AU2001270014 A AU 2001270014A AU 7001401 A AU7001401 A AU 7001401A AU 2001270014 A1 AU2001270014 A1 AU 2001270014A1
Authority
AU
Australia
Prior art keywords
isolation
compositions
identification
stem cells
stem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001270014A
Inventor
Andrew N. Makarovskiy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhode Island Hospital
Original Assignee
LIFESPAN PARTNER RHODE ISLAND
Rhode Island Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LIFESPAN PARTNER RHODE ISLAND, Rhode Island Hospital filed Critical LIFESPAN PARTNER RHODE ISLAND
Publication of AU2001270014A1 publication Critical patent/AU2001270014A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2001270014A 2000-06-22 2001-06-21 Compositions for identification and isolation of stem cells Abandoned AU2001270014A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/603,453 US6632620B1 (en) 2000-06-22 2000-06-22 Compositions for identification and isolation of stem cells
US09/603,453 2000-06-22
PCT/US2001/019771 WO2001098358A2 (en) 2000-06-22 2001-06-21 Compositions for identification and isolation of stem cells

Publications (1)

Publication Number Publication Date
AU2001270014A1 true AU2001270014A1 (en) 2002-01-02

Family

ID=24415497

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001270014A Abandoned AU2001270014A1 (en) 2000-06-22 2001-06-21 Compositions for identification and isolation of stem cells

Country Status (3)

Country Link
US (2) US6632620B1 (en)
AU (1) AU2001270014A1 (en)
WO (1) WO2001098358A2 (en)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632620B1 (en) * 2000-06-22 2003-10-14 Andrew N. Makarovskiy Compositions for identification and isolation of stem cells
US8044259B2 (en) * 2000-08-03 2011-10-25 The Regents Of The University Of Michigan Determining the capability of a test compound to affect solid tumor stem cells
US6984522B2 (en) 2000-08-03 2006-01-10 Regents Of The University Of Michigan Isolation and use of solid tumor stem cells
CA2461355A1 (en) * 2001-09-20 2003-04-03 Peter-Joachim Neymann Patient card
AU2003304106C1 (en) * 2002-05-17 2010-10-28 Mount Sinai School Of Medicine Of New York University Mesoderm and definitive endoderm cell populations
GB0406215D0 (en) * 2004-03-19 2004-04-21 Procure Therapeutics Ltd Prostate stem cell
EP1907858A4 (en) * 2005-06-13 2009-04-08 Univ Michigan Compositions and methods for treating and diagnosing cancer
US20070099209A1 (en) * 2005-06-13 2007-05-03 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
US7723477B2 (en) 2005-10-31 2010-05-25 Oncomed Pharmaceuticals, Inc. Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
WO2007053577A2 (en) 2005-10-31 2007-05-10 Oncomed Pharmaceuticals, Inc. Compositions and methods for diagnosing and treating cancer
JP5129149B2 (en) 2005-10-31 2013-01-23 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン Compositions and methods for treating and diagnosing cancer
EP2081590A4 (en) * 2006-09-07 2011-12-28 Stemline Therapeutics Inc Cancer stem cell-targeted cancer therapy
EP2526970A1 (en) * 2006-09-07 2012-11-28 Stemline Therapeutics, Inc. Monitoring cancer stem cells
EP2106439B1 (en) 2007-01-24 2014-11-12 The Regents of the University of Michigan Compositions and methods for treating and diagnosing pancreatic cancer
JP5792621B2 (en) 2008-09-26 2015-10-14 オンコメッド ファーマシューティカルズ インコーポレイテッド Frizzled binders and uses thereof
JP2012521786A (en) 2009-03-30 2012-09-20 モウント シナイ スクール オフ メディシネ Influenza virus vaccine and use thereof
WO2010138564A1 (en) 2009-05-26 2010-12-02 Mount Sinai School Of Medicine Of New York University Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof
TWI535445B (en) 2010-01-12 2016-06-01 安可美德藥物股份有限公司 Wnt antagonists and methods of treatment and screening
KR20120132506A (en) 2010-02-18 2012-12-05 마운트 시나이 스쿨 오브 메디슨 Vaccines for use in the prophylaxis and treatment of influenza virus disease
WO2011123495A1 (en) 2010-03-30 2011-10-06 Mount Sinai School Of Medicine Influenza virus vaccines and uses thereof
MX347515B (en) 2010-04-01 2017-04-28 Oncomed Pharmaceuticals Inc * Frizzled-binding agents and uses thereof.
WO2012048298A2 (en) 2010-10-08 2012-04-12 Caridianbct, Inc. Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
US10131695B2 (en) 2011-09-20 2018-11-20 Icahn School Of Medicine At Mount Sinai Influenza virus vaccines and uses thereof
EP2911691B1 (en) 2012-10-23 2018-10-10 OncoMed Pharmaceuticals, Inc. Methods of treating neuroendocrine tumors using wnt pathway-binding agents
CA2895508A1 (en) 2012-12-18 2014-06-26 Icahn School Of Medicine At Mount Sinai Influenza virus vaccines and uses thereof
WO2014121196A1 (en) 2013-02-04 2014-08-07 Oncomed Pharmaceuticals, Inc. Methods and monitoring of treatment with a wnt pathway inhibitor
WO2014159960A1 (en) 2013-03-14 2014-10-02 Icahn School Of Medicine At Mount Sinai Antibodies against influenza virus hemagglutinin and uses thereof
US9168300B2 (en) 2013-03-14 2015-10-27 Oncomed Pharmaceuticals, Inc. MET-binding agents and uses thereof
EP3068867B1 (en) 2013-11-16 2018-04-18 Terumo BCT, Inc. Expanding cells in a bioreactor
WO2015148704A1 (en) 2014-03-25 2015-10-01 Terumo Bct, Inc. Passive replacement of media
CN106715676A (en) 2014-09-26 2017-05-24 泰尔茂比司特公司 Scheduled feed
JP2018504412A (en) 2015-01-23 2018-02-15 アイカーン スクール オブ メディシン アット マウント サイナイ Influenza virus vaccination regimen
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US11965175B2 (en) 2016-05-25 2024-04-23 Terumo Bct, Inc. Cell expansion
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11266734B2 (en) 2016-06-15 2022-03-08 Icahn School Of Medicine At Mount Sinai Influenza virus hemagglutinin proteins and uses thereof
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
WO2018184028A2 (en) 2017-03-31 2018-10-04 Terumo Bct, Inc. Cell expansion
CA3058652A1 (en) 2017-04-07 2018-10-11 Icahn School Of Medicine At Mount Sinai Anti-influenza b virus neuraminidase antibodies and uses thereof
JP2024511064A (en) 2021-03-23 2024-03-12 テルモ ビーシーティー、インコーポレーテッド Cell capture and proliferation

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4714680B1 (en) 1984-02-06 1995-06-27 Univ Johns Hopkins Human stem cells
US5087570A (en) 1988-05-10 1992-02-11 Weissman Irving L Homogeneous mammalian hematopoietic stem cell composition
US5061620A (en) 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
EP0573564A1 (en) 1991-02-22 1993-12-15 Massachusetts Institute Of Technology Nestin expression as an indicator of neuroepithelial tumors
US5367057A (en) 1991-04-02 1994-11-22 The Trustees Of Princeton University Tyrosine kinase receptor flk-2 and fragments thereof
GB9108047D0 (en) 1991-04-16 1991-06-05 Mellors Alan The use of pasteurella haemolytica clycoproteinase for human bone marrow haematopoietic primitive stem-cell isolation
ES2198403T3 (en) 1991-06-18 2004-02-01 Osiris Therapeutics, Inc. HUMAN MESENCHIMATIC MOTHER CELLS DERIVED FROM MEDULA AND SPECIFIC MONOCLONAL ANTIBODIES FOR SUCH CELLS.
EP0597964A4 (en) 1991-08-07 1994-11-30 Einstein Coll Med Proliferation of hepatocyte precursors.
WO1993025216A1 (en) 1992-06-08 1993-12-23 Becton, Dickinson And Company Human primitive stem cells
US5677136A (en) 1994-11-14 1997-10-14 Systemix, Inc. Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
AU4965796A (en) 1995-01-24 1996-08-14 Board Of Regents, The University Of Texas System Self-renewing pluripotent hematopoietic stem cell compositions, methods of use, and culture systems therefor
AU6223296A (en) 1995-06-07 1996-12-30 Novartis Ag Methods for obtaining compositions enriched for hematopoieti c stem cells and antibodies for use therein
US5861313A (en) 1995-06-07 1999-01-19 Ontogeny, Inc. Method of isolating bile duct progenitor cells
US5773224A (en) 1996-02-12 1998-06-30 Grandics; Peter Immunoselection system for cell elution
AU3440797A (en) 1996-07-01 1998-01-21 Novartis Ag Process of obtaining compositions enriched for hematopoietic stem cells and antibodies for use therein
JP4404381B2 (en) 1997-03-10 2010-01-27 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア PSCA: Prostate stem cell antigen
US6258939B1 (en) * 1997-03-10 2001-07-10 The Regents Of The University Of California PSCA antibodies and hybridomas producing them
CA2219869A1 (en) 1997-10-31 1999-04-30 Hsc Research And Development Limited Partnership Human cd-34 hematopoietic stem cells
AU4221399A (en) 1998-05-29 1999-12-13 Osiris Therapeutics, Inc. Human cd45+ and/or fibroblast + mesenchymal stem cells
JP2002516085A (en) 1998-05-29 2002-06-04 トーマス・ジェファーソン・ユニバーシティ Compositions and uses that affect hematopoietic stem cell populations in mammals
US6632620B1 (en) * 2000-06-22 2003-10-14 Andrew N. Makarovskiy Compositions for identification and isolation of stem cells

Also Published As

Publication number Publication date
WO2001098358A3 (en) 2002-06-20
US6632620B1 (en) 2003-10-14
US7223549B2 (en) 2007-05-29
US20030134338A1 (en) 2003-07-17
WO2001098358A9 (en) 2003-03-06
WO2001098358A2 (en) 2001-12-27

Similar Documents

Publication Publication Date Title
AU2001270014A1 (en) Compositions for identification and isolation of stem cells
AU2002319780A1 (en) Alternative compositions and methods for the culture of stem cells
AU2001284160A1 (en) Modulation of stem cell differentiation
AU2001270273A1 (en) Valve manifold box and method of making same
AU2002319054A1 (en) Multipotent stem cells from peripheral tissues and uses thereof
EP1157707B8 (en) Method and composition for deforming soft tissues
ZA200500985B (en) Isolation and identification of T cells.
AU2002234597A1 (en) Branched primary alcohol compositions and derivatives thereof
AU2001233622A1 (en) Inhibition of beta cell degeneration
AU2001253255A1 (en) Compositions and methods for inhibiting gene expression
AU3459702A (en) Branched primary alcohol compositions and derivatives thereof
AU2001286315A1 (en) Stem cell-like cells
AU2001260847A1 (en) Compositions isolated from skin cells and methods for their use
AU2001288976A1 (en) Compositions and methods of use for extracts of rutaceae plants
AU2002348947A1 (en) Compositions and methods for amplification of human stem cells
EP1687411A4 (en) Hematopoietic stem cell identification and isolation
AUPR892501A0 (en) Method of enhancing self renewal of stem cells and uses thereof
AU2002211370A1 (en) Inhibition of tgf-beta and uses thereof
AUPR041900A0 (en) Manipulation of plant cell walls
AU2002219900A1 (en) Minimal identification of features
AU2002309330A1 (en) Isolation method of mesenchymal cells
AU2003299914A1 (en) Isolation and identification of cross-reactive t cells
AU2002364506A1 (en) Compositions for the derivation of germ cells from stem cells and methods of use thereof
AU2001294010A1 (en) Stem cells
AU2002224383A1 (en) Method and marker for the isolation of human multipotent hematopoietic stem cells